NCT02288559 A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy Status COMPLETED Phase PHASE2
NCT02247531 A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Status TERMINATED Phase PHASE3
NCT02247479 A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Status TERMINATED Phase PHASE3
NCT02137915 Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration Status TERMINATED Phase N/A
NCT02130531 Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration Status COMPLETED Phase PHASE1
NCT02087085 A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration Status TERMINATED Phase PHASE2
NCT01802866 Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride Status COMPLETED Phase PHASE2/PHASE3
NCT01782989 Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) Status COMPLETED Phase PHASE2/PHASE3
NCT01694095 Evolution and Risk Factors Associated With Geographic Atrophy Progression Status COMPLETED Phase N/A
NCT01692938 Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO Status COMPLETED Phase N/A
NCT01675947 Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy Status TERMINATED Phase PHASE2
NCT01666821 A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population Status COMPLETED Phase N/A
NCT01603043 A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD) Status TERMINATED Phase PHASE2
NCT01602120 An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy Status TERMINATED Phase PHASE2
NCT01527500 Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD) Status COMPLETED Phase PHASE2
NCT01445548 Sirolimus for Advanced Age-Related Macular Degeneration Status COMPLETED Phase PHASE1/PHASE2
NCT01272076 Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE) Status COMPLETED Phase N/A